Skip to main content
NCBI home page
Journal of Medical Toxicology logoLink to Journal of Medical Toxicology
. 2006 Mar;2(1):19–24. doi: 10.1007/BF03161009

Case files of the medical toxicology fellowship training program at the children’s hospital of Philadelphia: A pediatric exploratory sulfonylurea ingestion

Diane P Calello 1, Andrea Kelly 2, Kevin C Osterhoudt 1,✉
PMCID: PMC3550029  PMID: 18072108

Full Text

The Full Text of this article is available as a PDF (200.5 KB).

References

  • 1.Watson WA, Litovitz TL, Rodgers GC, Klein-Schwartz W, Reid N, Youniss J, et al. 2004 annual report of the American association of poison control centers toxic exposure surveillance system. Am J Emerg Med. 2005;23:589–666. doi: 10.1016/j.ajem.2005.05.001. [DOI] [PubMed] [Google Scholar]
  • 2.Litovitz TL, Klein-Schwartz W, Dyer KS, Shannon M, Lee S, Powers M. 1997 annual report of the American Association of Poison Control Centers toxic exposure surveillance system. Am J Emerg Med. 1998;16:443–497. doi: 10.1016/S0735-6757(98)90000-6. [DOI] [PubMed] [Google Scholar]
  • 3.Osterhoudt KC. Principles of epidemiology and research design. In: Goldfrank LR, Flomenbaum NE, Lewin NA, Howland MA, Hoffman RS, Nelson LS, editors. Goldfrank’s Toxicologic Emergencies. 7th ed. New York: McGraw Hill; 2002. pp. 1789–1797. [Google Scholar]
  • 4.Osterhoudt KC. Toxic topic: This treat is not so sweet: exploratory sulfonylurea ingestion by a toddler. Pediatr Case Reviews. 2003;4:215–217. doi: 10.1097/01.PCA.0000084259.60582.71. [DOI] [PubMed] [Google Scholar]
  • 5.Little GL, Boniface KS. Are one or two dangerous? Sulfonylurea exposure in toddlers. J Emerg Med. 2005;28:305–310. doi: 10.1016/j.jemermed.2004.09.012. [DOI] [PubMed] [Google Scholar]
  • 6.Osterhoudt KC. The toxic toddler: drugs that can kill in small doses. Contemp Pediatr. 2000;17:73–88. [Google Scholar]
  • 7.Bar-Oz B, Levichek Z, Koren G. Medications that can be fatal for a toddler with one tablet or teaspoonful: a 2004 update. Paediatric Drugs. 2004;6:123–6. doi: 10.2165/00148581-200406020-00005. [DOI] [PubMed] [Google Scholar]
  • 8.Michael JB, Sztajnkrycer MD. Deadly pediatric poisons: nine common agents that kill at low doses. Emerg Med Clin NA. 2004;22:1019–1050. doi: 10.1016/j.emc.2004.05.004. [DOI] [PubMed] [Google Scholar]
  • 9.Sketris L, Wheeler D, York S. Hypoglycemic coma induced by inadvertent administration of glyburide. Drug Intell Clin Pharm. 1984;18:142–143. doi: 10.1177/106002808401800210. [DOI] [PubMed] [Google Scholar]
  • 10.Quadrani DA, Spiller HA, Widder P. Five-year retrospective evaluation of sulfonylurea ingestion in children. J Toxicol Clin Toxicol. 1996;34:267–270. doi: 10.3109/15563659609013787. [DOI] [PubMed] [Google Scholar]
  • 11.Borowski H, Caraccio T, Mofensen H. Sulfonylurea ingestion in children: is an 8-hour observation period sufficient? J Pediatr. 1998;133:584–584. doi: 10.1016/s0022-3476(98)70080-0. [DOI] [PubMed] [Google Scholar]
  • 12.Szlatenyi CS, Capes KF, Wang RY. Delayed hypoglycemia in a child after ingestion of a single glipizide tablet. Ann Emerg Med. 1998;31:773–776. doi: 10.1016/S0196-0644(98)70240-9. [DOI] [PubMed] [Google Scholar]
  • 13.Greenberg B, Weihl C, Hug G. Chlorpropamide poisoning. Pediatrics. 1968;41:145–147. [PubMed] [Google Scholar]
  • 14.Palatnick W, Meatheral RC, Tenenbein M. Clinical spectrum of sulfonylurea overdose and experience with diazoxide therapy. Arch Intern Med. 1991;151:1859–1862. doi: 10.1001/archinte.151.9.1859. [DOI] [PubMed] [Google Scholar]
  • 15.Spiller HA, Villalobos D, Krenzolak EP, Anderson BD, Gorman SE, Rose SR, et al. Prospective multi-center study of sulfonylurea ingestion in children. J Pediatr. 1997;131:141–146. doi: 10.1016/S0022-3476(97)70138-0. [DOI] [PubMed] [Google Scholar]
  • 16.Robertson WO. Sulfonylurea ingestions: hospitalization not mandatory. J Toxicol Clin Toxicol. 1997;35:115–116. doi: 10.3109/15563659709001178. [DOI] [PubMed] [Google Scholar]
  • 17.Robertson WO. Delayed hypoglycemia after ingestion of a single glipizide tablet [letter, comment] Ann Emerg Med. 1999;33:130–130. [PubMed] [Google Scholar]
  • 18.Burkhart KK. When does hypoglycemia develop after sulfonylurea ingestion? Ann Emerg Med. 1998;31:771–772. doi: 10.1016/S0196-0644(98)70239-2. [DOI] [PubMed] [Google Scholar]
  • 19.Spiller HA. Management of sulfonylurea ingestions. Pediatr Emerg Care. 1999;15:227–230. doi: 10.1097/00006565-199906000-00015. [DOI] [PubMed] [Google Scholar]
  • 20.Thomas DK. Hypoglycemia in children before operation: its incidence and prevention. Br J Anesth. 1974;46:66–68. doi: 10.1093/bja/46.1.66. [DOI] [PubMed] [Google Scholar]
  • 21.Marin G, Rose SR, Kibarian M, Barnes K, Cassorla F. Absence of dawn phenomenon in normal children and adolescents. Diabetes Care. 1988;11:393–396. doi: 10.2337/diacare.11.5.393. [DOI] [PubMed] [Google Scholar]
  • 22.Graudins A, Linden CH, Ferm RP. Diagnosis and treatment of sulfonylurea-induced hyperinsulinemic hypoglycemia. Am J Emerg Med. 1997;15:95–96. doi: 10.1016/S0735-6757(97)90062-0. [DOI] [PubMed] [Google Scholar]
  • 23.Ingels M. Hypoglycemic agents and insulin. In: Erickson TB, Ahrens WR, Aks SE, Baum CR, Ling LJ, editors. Pediatric Toxicology. New York: McGraw Hill; 2005. pp. 277–282. [Google Scholar]
  • 24.Boyle PJ, Justice K, Krentz AJ, Nagy RJ, Schade DS. Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses. J Clin Endocrinol Metab. 1993;76:752–756. doi: 10.1210/jc.76.3.752. [DOI] [PubMed] [Google Scholar]
  • 25.McLaughlin SA, Crandall CS, McKinney PE. Octreotide: an antidote for sulfonylurea-induced hypoglycemia. Ann Emerg Med. 2000;36:133–138. doi: 10.1067/mem.2000.108183. [DOI] [PubMed] [Google Scholar]
  • 26.Carr R, Zed PJ. Octreotide for sulfonylurea-induced hypoglycemia following overdose. Annals Pharmacother. 2002;36:1727–1732. doi: 10.1345/aph.1C076. [DOI] [PubMed] [Google Scholar]
  • 27.Glaser B, Hirsch HJ, Landau H. Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. J Pediatr. 1993;123(4):644–50. doi: 10.1016/S0022-3476(05)80970-9. [DOI] [PubMed] [Google Scholar]
  • 28.Radetti G, Gentili L, Paganini C, Messner H. Cholelithiasis in a newborn following treatment with the somatostatin analogue octreotide. Eur J Pediatr. 2000;159(7):550–550. doi: 10.1007/s004310051335. [DOI] [PubMed] [Google Scholar]
  • 29.Thornton PS, Alter CA, Katz LE, Baker L, Stanley CA. Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism. J Pediatr. 1993;123(4):637–43. doi: 10.1016/S0022-3476(05)80969-2. [DOI] [PubMed] [Google Scholar]
  • 30.Arevalo RP, Bullabh P, Krauss AN, Auld PA, Spigland N. Octreotide-induced hypoxemia and pulmonary hypertension in premature neonates. J Pediatr Surg. 2003;38(2):251–3. doi: 10.1053/jpsu.2003.50056. [DOI] [PubMed] [Google Scholar]
  • 31.Mordel A, Sivilotti MLA, Old AC, Ferm RP. Octreotide for pediatric sulfonylurea poisoning [abstract] J Toxicol Clin Toxicol. 1998;36:437–437. [Google Scholar]
  • 32.Kent DA, Main BA, Friesen MS. Use of octreotide in sulfonylurea poisoning in a child [abstract] J Toxicol Clin Toxicol. 1993;41:669–669. [Google Scholar]
  • 33.Calello DP, Osterhoudt KC, Henretig FM, Perrone J. Octreotide for pediatric sulfonylurea overdose: Review of 5 cases [abstract] Clin Toxicol. 2005;43:671–671. [Google Scholar]

Articles from Journal of Medical Toxicology are provided here courtesy of Springer

RESOURCES